Founded in 2017 under the Rectorate of Yeditepe University, the Yeditepe University Faculty of Pharmacy, Pharmaceuticals, Cosmetics, and Medical Devices R&D Laboratory (YUEF-IKTAL) is a research-driven facility that supports innovation across pharmaceuticals, cosmetics, and medical devices.
YUEF-IKTAL advances public health by generating evidence and delivering solutions throughout the product lifecycle, from research and development to manufacturing support and safety monitoring. We also collaborate with industry partners, providing capabilities for preclinical efficacy and safety studies of products in this sector.
To align with national and international regulatory requirements, YUEF-IKTAL operates under a defined policy framework and maintains a Quality Management System compliant with TS EN ISO/IEC 17025. The laboratory is accredited by the Turkish Accreditation Agency (TÜRKAK) for 13 test methods, reflecting our commitment to competence, traceability, and reliability.
Human health stands at the center of our work. For this reason, we conduct our R&D activities with transparency, integrity, openness, ethical rigor, and dependable scientific practice.
By strengthening the R&D capacity of the national industry, YUEF-IKTAL aims to contribute to the development of high-value-added, innovative products with impact in Türkiye and internationally.
Laboratories within YUEF-IKTAL
* Cell Culture Laboratory (TOKSLAB)
* Toxicology Research and Application Laboratory (TOKSLAB)
* Electrochemistry Laboratory (KIMLAB)
* Multidisciplinary Analysis Laboratory I (KIMLAB)
* Multidisciplinary Analysis Laboratory II (KIMLAB)
* Microbiology Laboratory (MIKLAB)
* Pharmacognosy and Phytotherapy R&D Laboratory I (FITOLAB)
* Pharmacognosy and Phytotherapy R&D Laboratory II (FITOLAB)
* Pharmacognosy and Phytotherapy R&D Laboratory III (FITOLAB)
Within the Toxicity Research and Application Laboratory under the Department of Pharmaceutical Toxicology, YUEF-IKTAL conducts the following analyses and evaluations in accordance with published national and/or international guidelines:
* Preclinical toxicity testing for new drug candidates
* Medical device biocompatibility testing
* Medical device chemical, physical, and performance testing
* Cosmetic efficacy and safety testing
* Cosmetic safety assessment
* Toxicological risk assessment for chemicals, biocidal products, cosmetics, and other consumer products
* Impurity-focused toxicological risk assessment and analysis for APIs and finished products
* Toxicological risk assessment based on extractables/leachables (E&L) outcomes for pharmaceuticals and medical devices
* Environmental Risk Assessment (ERA) for pharmaceuticals
* Permitted Daily Exposure (PDE) and Occupational Exposure Limit (OEL) assessments for APIs
* In vitro and in vivo evaluation of free radical toxicity and antioxidant activity for chemical and natural substances
* Heavy metal and trace element analysis across all material types
* Microbiological analysis for pharmaceutical, medical device, and cosmetic products